Concentration-dependent Bioavailability
Concentration-Dependent Bioavailability is a pharmacokinetic construct that denotes the nonlinear relationship between the administered concentration of a substance and its systemic availability due to saturable absorption mechanisms.
88
Publications
3.8K
Citations
398
Authors
126
Institutions
Publications per year
2017–2026
23
Parents
88
Clinical pharmacokinetics of gabapentin.
Michael J. McLean · PubMed · 1994 · 263 citations
Johan Karlsson, Shiu‐Ming Kuo, John A. Ziemniak et al. · British Journal of Pharmacology · 1993 · 180 citations · Full text
Medicine, Cell Biology, Pharmacology +17
1–5 of 88
398
3
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 398
126
Shenyang Pharmaceutical University
Shenyang, China
3 h-index
23 publications
1.3K citations

Uppsala University
Uppsala, Sweden
2 h-index
5 publications
447 citations
Oklahoma State University Center for Health Sciences
Tulsa, United States
2 h-index
7 publications
310 citations
University of Wisconsin–Madison
Madison, United States
2 h-index
7 publications
310 citations
University of Nebraska–Lincoln
Lincoln, United States
2 h-index
2 publications
50 citations

Icahn School of Medicine at Mount Sinai
New York, United States
2 h-index
13 publications
818 citations
University at Buffalo, State University of New York
Buffalo, United States
1 h-index
1 publications
180 citations
AbbVie (United States)
North Chicago, United States
1 h-index
2 publications
104 citations
1–8 of 126
Repository · 9 publications · 473 citations
8
h-index
6 publications · 249 citations
6
h-index
JPP · 5 publications · 65 citations
5
h-index
4 publications · 133 citations
4
h-index
3 publications · 320 citations
3
h-index
1–5